Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154359 | SCV000204022 | likely benign | not specified | 2015-07-30 | criteria provided, single submitter | clinical testing | p.Thr4918Met in exon 67 of USH2A: This variant is not expected to have clinical significance because it has been identified in 0.2% (119/66710) of European chro mosomes, including 1 homozygous individual, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs56136489). Threonine (Thr) at pos ition 4918 is not conserved in mammals or evolutionarily distant species and 1 m ammal (Pacific walrus) carries a methionine (Met) at this position, suggesting t his change may be tolerated. Additional computational prediction tools do not pr ovide strong support for or against an impact to the protein. Although this vari ant has been reported in one individual with Usher syndrome type II, the authors classified it as a variant of uncertain significance and did not clarify whethe r a second USH2A variant was found in the individual (McGee 2010). |
Eurofins Ntd Llc |
RCV000724181 | SCV000231964 | uncertain significance | not provided | 2014-10-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724181 | SCV000616915 | uncertain significance | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | Identified in a patient with Usher syndrome type II in published literature, however no information about a second variant was provided (McGee et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32707200, 24944099, 20507924) |
Labcorp Genetics |
RCV000724181 | SCV001115362 | likely benign | not provided | 2025-01-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000724181 | SCV001473486 | uncertain significance | not provided | 2019-09-25 | criteria provided, single submitter | clinical testing | The USH2A c.14753C>T; p.Thr4918Met variant (rs56136489) is reported in the literature in an individual affected with Usher syndrome type 2, although it was not demonstrated to be disease-causing and a second variant in this individual was not reported (McGee 2010). This variant is found in the general population with an overall allele frequency of 0.12% (331/282718 alleles, including one homozygote) in the Genome Aggregation Database. The threonine at codon 4918 is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, due to limited information, the clinical significance of the p.Thr4918Met variant is uncertain at this time. References: McGee TL et al. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet. 2010 Jul;47(7):499-506. |
Ce |
RCV000724181 | SCV002821455 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BS2 |
Institute of Human Genetics, |
RCV004815236 | SCV005070423 | uncertain significance | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272929 | SCV001455380 | likely benign | Usher syndrome type 2A | 2020-06-04 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000724181 | SCV001952264 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724181 | SCV001975513 | uncertain significance | not provided | no assertion criteria provided | clinical testing |